Effects of modulating TGF-β1 on immune responses to mycobacterial infection in guinea pigs

Tubercle and Lung Disease

Volumn 79, Issue 4, 1999, Pages 207-214

  Dai, G ^a   McMurray, D N ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE COURSE; DISEASE RESISTANCE; GUINEA PIG; IMMUNE RESPONSE; IMMUNOMODULATION; LUNG; LYMPHOCYTE PROLIFERATION; MONONUCLEAR CELL; MYCOBACTERIOSIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PERITONEUM; PRIORITY JOURNAL; PROTEIN DIET; SPLEEN; VACCINATION;

EID: 0032855825     PISSN: 09628479     EISSN: None     Source Type: Journal    
DOI: 10.1054/tuld.1998.0198     Document Type: Article

References (34)

1. Britton W J, Roche P W, Winter N. Mechanisms of persistence of mycobacteria. Trends in Microbiol. 2:1994;284-288.
2. Cooper A M, Flynn J L. The protective immune response to Mycobacterium tuberculosis. Current Opinion in Immunol. 7:1995;512-516.
3. Wahl S M. Transforming growth factor beta in inflammation: a cause and a cure. J Clin Immunol. 12:1992;1-14.
4. Wahl S M, Allen J B, Weeks B S. TGF-beta; enhances intergrin expression and type IV collagenase secretion in human monocytes. Proc Natl Acad Sci USA. 90:1993;4577-4581.
5. Adams D H, Hathaway M, Shaw J. TGF-beta; induces human T lymphocyte migration in vitro. J Immunol. 147:1991;609-612.
6. Brandes M E, Mai U E H, Ohura K, Wahl S M. Human neutrophils express type I TGF-beta; receptors and chemotax to TGF-beta; J Immunol. 147:1991;1600-1606.
7. McCartney-Francis N, Wahl S M. Transforming growth factor beta: a matter of life and death. J Leukocyte Bio. 55:1994;401-409.
8. Ahuja S S, Fotini P, Yamada H, Balow J E, Boumpas D T. Effect of transforming growth factor beta on early and late activation events in human T cells. J Immunol. 150:1993;3109-3188.
9. Kehrl J H, Thevenin C, Rieckmann P, Fauci A. Transforming growth factor beta suppresses human B lymphocyte Ig production by inhibiting synthesis and switch from the membrane form to the secreted form of Ig mRNA. J Immunol. 146:1991;4016-4023.
10. D'Angeac A D, Dornand J, Emonds J A, Garciasanz A X, Erard F. Transforming growth factor-b1 down-regulates interleukin-2 production and up-regulates interleukin-2 receptor expression in a thymoma cell line. J Cell Physiol. 147:1991;460-465.
11. Espevick T, Figari I S, Shalaby M R. Inhibition of cytokine production by cyclosporin A and transforming growth factor beta. J Exp Med. 166:1987;571-576.
12. Rook A H, Kehrl J H, Wakefield L M. Effects of transforming growth factor beta on the functions of natural killer cells: depressed cytolytic activity and blunting of interferon responsiveness. J Immunol. 136:1986;3916-3921.
13. Mule J J, Schwarz S L, Roberts A B, Sporn M B, Rosenberg S A. Transforming growth factor beta inhibits the in vitro generation of lymphokine-activated killer cells and cytotoxic T cells. Cancer Immunol Immunother. 26:1988;951-957.
14. Tsunawaki S, Sporn M, Ding A, Nathan C. Deactivation of macrophages by transforming growth factor beta. Nature. 334:1988;260-261.
15. Ding A, Nathan C F, Graycar J, Derynck R, Stuehr D L, Srimal S. Macrophage deactivating factor and transforming growth factor-beta;1, -beta;2, -beta;3 inhibit induction of macrophage nitrogen oxide synthesis by IFN-γ J Immunol. 145:1990;940-944.
16. Toossi Z, Gogate P, Shiratsuchi H, Young T, Ellner J J. Enhanced production of TGF-beta; by blood monocytes from patients with active tuberculosis and presence of TGF-beta; in tuberculous granulomatous lung lesions. J Immunol. 154:1995;465-473.
17. Maeda J, Ueki N, Ohkawa T. Local production and localization of transforming growth factor-beta in tuberculous pleurisy. Clin Exp Immunol. 92:1993;32-38.
18. Hirsch C S, Yoneda T, Averill L E, Ellner J J, Toossi Z. Enhancement of intracellular growth of Mycobacterium tuberculosis in human monocytes by transforming growth factor-beta;1. J Infect Dis. 170:1994;1229-1237.
19. Hirsch C S, Hussain R, Toossi Z, Dawood G, Shahid F, Ellner J J. Cross-modulation by transforming growth factor beta; in human tuberculosis: suppression of antigen-driven blastogenesis and interferon γ production. Proc Natl Acad Sci USA. 93:1996;3193-3198.
20. Cohen M K, Bartow R A, Mintzer C L, McMurray D N. Effects of diet and genetics on Mycobacterium bovis BCG vaccine efficacy in inbred guinea pigs. Infect Immun. 55:1987;314-319.
21. McMurray D N, Mintzer C L, Bartow R A, Parr R L. Dietary protein deficiency and Mycobacterium bovis BCG affect interleukin-2 activity in experimental pulmonary tuberculosis. Infect Immun. 57:1989;2606-2611.
22. McMurray D N, Carlomagno M A, Mintzer C L, Tetzlaff C L. Mycobacterium bovis BCG vaccine fails to protect protein-deficient guinea pigs against respiratory challenge with virulent Mycobacterium tuberculosis H37Rv. Infect Immun. 50:1985;555-559.
23. Dai G, McMurray D N. Mechanisms of impaired antimycobacterial immunity in protein malnourished guinea pigs. Infect Immun. 66:1998;3562-3568.
24. McMurray D N, Yetley E A. Response to Mycobacterium bovis BCG vaccination in protein- and zinc-deficient guinea pigs. Infect Immun. 39:1983;755-761.
25. Grover A A, Kim H K, Wiegeshaus E H, Smith D W. Host-parasite relationships in experimental airborne tuberculosis. II. Reproducible infection by means of an inoculum preserved at -70°C. J Bacteriol. 94:1967;832-840.
26. Wiegeshaus E H, McMurray D N, Grover A A, Harding G E, Smith D W. Host-parasite relationships in experimental airborne tuberculosis. III. Relevance of microbial enumeration to acquired resistance in guinea pigs. Am Rev Respir Dis. 102:1970;422-429.
27. Smith D W, McMurray D N, Wiegeshaus E H, Grover A A, Harding G E. Host-parasite relationships in experimental airborne tuberculosis. IV. Early events in the course of infection in vaccinated and nonvaccinated guinea pigs. Am Rev Resp Dis. 102:1970;937-949.
28. Espevik T, Nissen-Meyer J. A highly sensitive cell line, WEHI 164 clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytes. J Immunol Methods. 95:1986;99-105.
29. Huygen K, Paleliet K, Jurio F, Hilgers J, Berg R T, Vooren J P V, Bruyn J D. H-2-linked control of in vitro gamma interferon production in response to a 37-kilodalton antigen (P32) ofMycobacterium bovis Bacillus Calmette-Guerin. Infect Immun. 56:1988;3196-3200.
30. Kelley J. Transforming growth factor-beta; Kelley J. Cytokines of the lung. 1993;101-137 Marcel Dekker, Inc. New York.
31. Denis M, Ghadirian E. Transforming growth factor beta plays a detrimental role in the progression of experimental Mycobacterium avium infection; in vivo and in vitro evidence. Microbial Pathogenesis. 11:1991;367-372.
32. Chan J, Tian Y, Tanaka K E. Effects of protein calorie malnutrition on tuberculosis in mice. Proc Natl Acad Sci USA. 93:1996;14875-14861.
33. Chandrasekar B, McGuff H S, Aufdermorte T B, Troyer D A, Talal N, Fernandes G. Effects of calorie restriction on transforming growth factor beta;1 and proinflammatory cytokines in murine Sjogren's syndrome. Clin Immunol Immunopathol. 76:1995;291-296.
34. Okuda S, Nakamura T, Yamamoto T, Ruoslahti E, Border W A. Dietary protein restriction rapidly reduces transforming growth factor beta-1 expression in experimental glomerulonephritis. Proc Natl Acad Sci USA. 88:1991;9765-9769.